Park, S. Y., Jeong, K. J., Poire, A., Zhang, D., Tsang, Y. H., Blucher, A. S., & Mills, G. B. (2023). Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer. Cell death & disease, 14(8), 532-12. https://doi.org/10.1038/s41419-023-06042-1
Citace podle Chicago (17th ed.)Park, Soon Young, Kang Jin Jeong, Alfonso Poire, Dong Zhang, Yiu Huen Tsang, Aurora S. Blucher, a Gordon B. Mills. "Irreversible HER2 Inhibitors Overcome Resistance to the RSL3 Ferroptosis Inducer in Non-HER2 Amplified Luminal Breast Cancer." Cell Death & Disease 14, no. 8 (2023): 532-12. https://doi.org/10.1038/s41419-023-06042-1.
Citace podle MLA (9th ed.)Park, Soon Young, et al. "Irreversible HER2 Inhibitors Overcome Resistance to the RSL3 Ferroptosis Inducer in Non-HER2 Amplified Luminal Breast Cancer." Cell Death & Disease, vol. 14, no. 8, 2023, pp. 532-12, https://doi.org/10.1038/s41419-023-06042-1.